Mark Worthington - Jan 18, 2022 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
General Counsel
Signature
/s/ Glenna Mileson, Attorney-in-fact for Mark Worthington
Stock symbol
ATHA
Transactions as of
Jan 18, 2022
Transactions value $
$0
Form type
4
Date filed
1/20/2022, 04:27 PM
Previous filing
Nov 5, 2021
Next filing
Jun 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHA Stock Option (Right to Buy) Award $0 +150K $0.00 150K Jan 18, 2022 Common Stock 150K $10.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth (1/48th) of the shares subject to the option will vest on February 18, 2022, and one forty-eighth of the shares subject to the option will vest each month thereafter.